Table 4 Pre-transplant biopsy results in the DGF and non-DGF groups
Lesions in pre-transplant biopsy | Degree | Non DGF group | DGF group | P value |
|---|---|---|---|---|
Chronic lesions | ||||
Glomerular sclerosis | None | 257 (65.1%) | 40 (41.7%) | < 0.001 |
Mild | 134 (33.9%) | 51 (53.1%) | Â | |
Moderate | 4 (1.0%) | 5 (5.2%) | Â | |
Severe | 0 (0.0%) | 0 (0.0%) | Â | |
Tubular atrophy | None | 256 (64.8%) | 40 (41.7%) | < 0.001 |
Mild | 135 (34.2%) | 27 (28.1%) | Â | |
Moderate | 4 (1.0%) | 0 (0.0%) | Â | |
Severe | 0 (0.0%) | 0 (0.0%) | Â | |
Interstitial fibrosis | None | 257 (65.1%) | 40 (41.7%) | < 0.001 |
Mild | 134 (33.9%) | 51 (53.1%) | Â | |
Moderate | 4 (1.0%) | 5 (5.2%) | Â | |
Severe | 0 (0.0%) | 0 (0.0%) | Â | |
Arterial intimal hyperplasia | None | 204 (51.8%) | 29 (30.2%) | < 0.001 |
Mild | 146 (37.1%) | 40 (41.7%) | Â | |
Moderate | 43 (10.9%) | 27 (28.1%) | Â | |
Severe | 1 (0.3%) | 0 (0.0%) | Â | |
Mesangial matrix hyperplasia | None | 284 (75.1%) | 41 (46.6%) | < 0.001 |
Mild | 83 (22.0%) | 40 (45.5%) | Â | |
Moderate | 11 (2.9%) | 5 (5.7%) | Â | |
Severe | 0 (0.0%) | 2 (2.3%) | Â | |
Arterial hyaline degeneration | None | 238 (60.4%) | 52 (54.2%) | 0.541 |
Mild | 72 (18.3%) | 23 (24.0%) | Â | |
Moderate | 82 (20.8%) | 20 (20.8%) | Â | |
Severe | 2 (0.5%) | 1 (1.0%) | Â | |
Acute lesions | ||||
Acute tubular injury | None | 0 (0.0%) | 0 (0.0%) | < 0.001 |
Mild | 366 (92.7%) | 63 (65.6%) | Â | |
Moderate | 26 (6.6%) | 30 (31.2%) | Â | |
Severe | 3 (0.8%) | 3 (3.1%) | Â | |
Arteriolar smooth muscle vacuolar degeneration | None | 113 (81.9%) | 26 (70.3%) | 0.040 |
Mild | 19 (13.8%) | 11 (29.7%) | Â | |
Moderate | 6 (4.3%) | 0 (0.0%) | Â | |
Severe | 0 (0.0%) | 0 (0.0%) | Â | |